Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1162 of 5804
-
New hope for rare blood cancer: pacritinib trial opens for patients who need better options
Disease control Recruiting nowThis study is being done to examine the safety and effectiveness of pacritinib as a possible treatment for participants with Waldenström macroglobulinemia (WM). The name of the study drug involved in this study is: -Pacritinib (a type of kinase inhibitor)
Phase: PHASE2 • Sponsor: Shayna Sarosiek, MD • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New hope for tough prostate cancer? early trial launches
Disease control Recruiting nowStudy K36-MCRPC-001 is the first in human clinical trial testing KTX-2001 alone and with darolutamide in men with metastatic castration-resistant prostate cancer. The study aims to assess whether the drug is safe, increasing doses alone and in combination with darolutamide, wheth…
Phase: PHASE1 • Sponsor: K36 Therapeutics, Inc. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Freezing lung nodules: a new hope for inoperable patients?
Disease control Recruiting nowLung cancer is the leading cause of cancer-related mortality worldwide, making early diagnosis and intervention critical. With the widespread adoption of low-dose computed tomography (LDCT) screening, the detection rate of pulmonary ground-glass nodules (GGNs) has increased signi…
Phase: NA • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New drug PT0511 targets Hard-to-Treat KRAS cancers in early trial
Disease control Recruiting nowThe primary purpose of this study is to evaluate the safety and tolerability, determine the maximally tolerated dose (MTD) and/or recommended Phase 2 dose(s) (RP2D) of PT0511 in adult participants with solid tumors as monotherapy and in combination with cetuximab in participants …
Phase: PHASE1 • Sponsor: PAQ Therapeutics, Inc. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Doctors test freezing technique to zap lung cancer without surgery
Disease control Recruiting nowThis clinical trial is an exploratory clinical trial with two cohorts: Cohort 1: aiming to conduct a preliminary evaluation of the effectiveness and safety of the Navigational Bronchoscopy System and the Bronchoscope and Accessories (manufactured by Noah) in combination with the…
Phase: NA • Sponsor: Tianjin Puli Ark Medical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Intensive hand therapy shows promise for kids with cerebral palsy
Symptom relief Recruiting nowCerebral palsy is the most common motor disability in children. Individuals with CP often experience significant difficulties in the use of their upper limbs, which affects their autonomy and quality of life. Conventional rehabilitation, although essential, is often insufficient …
Phase: NA • Sponsor: Fondation Ellen Poidatz • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New shot takes on tough blood cancers in small safety trial
Disease control Recruiting nowThis is an investigator-initiated, single-arm, open-label clinical study. It employs a dose-escalation design to evaluate the safety, pharmacokinetics, and preliminary efficacy of IASO208 injection in relapsed/refractory B-cell malignancies.
Phase: PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug cocktail aims to shrink kidney tumors before surgery
Disease control Recruiting nowThrough the combination of aparolitovorelli monoclonal antibody and lenvatinib neoadjuvant therapy, partial nephrectomy can be successfully and safely performed in patients with localized renal cell carcinoma (T1N0M0 or T2N0M0) who have indications for kidney preservation surgery…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New hope for chronic coughers: experimental drug enters final testing phase
Symptom relief Recruiting nowThis is a randomized, double-blind, placebo-controlled, parallel-arm, Phase 3 study of BLU-5937 in participants with Refractory Chronic Cough (RCC).
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Heart failure patients may soon get fluid relief at home with a simple shot
Symptom relief Recruiting nowThe primary objective of the study is to develop, implement, and evaluate a site-specific clinical pathway for at-home treatment of eligible patients presenting to the clinic with worsening heart failure. The secondary objectives are: 1. To evaluate patient factors related to p…
Phase: PHASE4 • Sponsor: University of Florida • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Can a short talk with biofeedback ease trauma after cancer surgery?
Symptom relief Recruiting nowHead and neck cancer and its surgical treatment may significantly affect patients' psychological well-being, body image, somatic experience, and quality of life. This pilot randomized controlled non-pharmacological study aims to evaluate the short-term efficacy of a brief clinica…
Phase: NA • Sponsor: University of Turin, Italy • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Tiny heart device could patch leaky valve without surgery
Disease control Recruiting nowThe purpose of this clinical trial is as follows. To assess the safety of the investigational medical device "Pivot Bridge" in participants aged 18 years or older with massive or greater functinal tricuspid regurgitation (TR) who have received medical therapy (diuretics/pharmaco…
Phase: NA • Sponsor: Tau-MEDICAL Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could a gout drug help heal brain bleeds?
Disease control Recruiting nowTo assess the effect of Febuxostat on clinical outcomes and biomarkers of oxidative stress and inflammation in patients with conservatively managed intracranial hemorrhage.
Phase: PHASE2 • Sponsor: Tanta University • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New capsule aims to fight rare eye cancer that spreads
Disease control Recruiting nowThis study is being done to find the best dose of an investigational drug called NBM-BMX for people with metastatic uveal melanoma, a type of eye cancer that has spread to other parts of the body. The study will help doctors learn about the side effects of NBM-BMX, how the drug …
Phase: PHASE1, PHASE2 • Sponsor: Novelwise Pharmaceutical Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could a menstrual cup replace painful biopsies for cancer screening?
Diagnosis Recruiting nowStudy Goal: This pilot study wants to find out if using a menstrual cup can be a good, non-invasive way to collect samples from the lining of the uterus (called the endometrium) to help screen for endometrial cancer. This is especially important for women who have a higher chanc…
Phase: NA • Sponsor: Jessica D. St. Laurent, MD • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
New pill could ease severe eczema itch and rash
Symptom relief Recruiting nowThe purpose of this study is to learn if the study medicine (PF-08049820) is safe and effective for the treatment of atopic dermatitis (AD), also known as eczema, or atopic eczema. People with this condition may have severe itching and rashes on the skin. The study is seeking pa…
Phase: PHASE2 • Sponsor: Pfizer • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Smartwatch and app may predict asthma attacks in kids before they strike
Knowledge-focused Recruiting nowThe objective of this study is to determine whether healthcare data and remotely collected patient data can accurately predict asthma attacks in children and young people aged 5-17 years. The main outcome is: when using this new system, is there a reduction in asthma attacks com…
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
New drug SHR-4610 tested in patients with Hard-to-Treat cancers
Disease control Recruiting nowThis study is an open, multicenter Phase I/II clinical trial, divided into two stages: dose exploration (including dose escalation and dose extension) and efficacy extension.
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Shengdi Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Could a tiny mesh device ease stubborn chest pain?
Disease control ENROLLING_BY_INVITATIONCoronary microvascular dysfunction (CMD) is a common cause of treatment- resistant angina that lacks evidence-based treatment options. The coronary sinus reducer (CSR) is an hourglass-shaped stainless steel mesh, designed to create a controlled narrowing of the coronary sinus (CS…
Phase: NA • Sponsor: UMC Utrecht • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New trial burns tumors from inside to fight bile duct cancer
Disease control Recruiting nowThis international, multicenter, open-label randomized controlled trial evaluates whether repeated endobiliary radiofrequency ablation (EB-RFA) improves overall survival in patients with unresectable extrahepatic cholangiocarcinoma undergoing first-line systemic therapy with durv…
Phase: NA • Sponsor: Aichi Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC